These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9528183

  • 1. [Precancerous states of the endometrium: hormonal aspects].
    Foidart JM, Gilliquet A, Nondonfaz N, Goffin F, Kridelka F, Dubois M.
    Bull Acad Natl Med; 1997 Oct; 181(7):1395-404; discussion 1404-5. PubMed ID: 9528183
    [Abstract] [Full Text] [Related]

  • 2. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF.
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [Abstract] [Full Text] [Related]

  • 3. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK, McConnell T, Potoczek M, Emmons RV, Kurman RJ.
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M.
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hormonal pathology of the endometrium.
    Deligdisch L.
    Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular and pathologic aspects of endometrial carcinogenesis.
    Hecht JL, Mutter GL.
    J Clin Oncol; 2006 Oct 10; 24(29):4783-91. PubMed ID: 17028294
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
    Horrée N, van Diest PJ, van der Groep P, Sie-Go DM, Heintz AP.
    J Clin Pathol; 2008 Jan 10; 61(1):36-42. PubMed ID: 17483252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC, Meinel A, Handzel R, Einenkel J.
    Ann Diagn Pathol; 2007 Aug 10; 11(4):297-311. PubMed ID: 17630117
    [Abstract] [Full Text] [Related]

  • 15. Postmenopausal hormone replacement therapy: endometrial and breast effects.
    Yeh IT.
    Adv Anat Pathol; 2007 Jan 10; 14(1):17-24. PubMed ID: 17198307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)].
    Beliaeva LA, Bukhvalov IB, Zheleznov BI, Raĭkhlin NT.
    Arkh Patol; 1982 Jan 10; 44(4):18-25. PubMed ID: 7082195
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep 10; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.